BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19844853)

  • 1. Perspectives in Lung Cancer--Third Asian-pacific Conference. 11-12 September 2009, Bangkok, Thailand.
    Lopes Gde L
    IDrugs; 2009 Nov; 12(11):689-91. PubMed ID: 19844853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the future of non-small cell lung cancer treatment.
    Ramalingam S
    Manag Care; 2005 Feb; 14(2 Suppl):9-13; discussion 13-4. PubMed ID: 15776956
    [No Abstract]   [Full Text] [Related]  

  • 3. Modern treatment of lung cancer: case 1. Amplification and mutation of the epidermal growth factor receptor in metastatic lung cancer with remission from gefitinib.
    Schwab R; Pinter F; Moldavy J; Papay J; Strausz J; Kopper L; Keri G; Pap A; Petak I; Oreskovich K; Mangel L
    J Clin Oncol; 2005 Oct; 23(30):7736-8. PubMed ID: 16234532
    [No Abstract]   [Full Text] [Related]  

  • 4. Developing targeted therapies for lung cancer.
    Gandara DR
    Clin Adv Hematol Oncol; 2003 Nov; 1(11):648-9, 690. PubMed ID: 16258461
    [No Abstract]   [Full Text] [Related]  

  • 5. Epidermal growth factor receptor mutations in lung cancer.
    Sharma SV; Bell DW; Settleman J; Haber DA
    Nat Rev Cancer; 2007 Mar; 7(3):169-81. PubMed ID: 17318210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphisms of the epidermal growth factor and related receptor in non-small cell lung cancer--a review of the literature.
    Araújo A; Ribeiro R; Azevedo I; Coelho A; Soares M; Sousa B; Pinto D; Lopes C; Medeiros R; Scagliotti GV
    Oncologist; 2007 Feb; 12(2):201-10. PubMed ID: 17296816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New targets for non-small-cell lung cancer therapy.
    Alvarez M; Roman E; Santos ES; Raez LE
    Expert Rev Anticancer Ther; 2007 Oct; 7(10):1423-37. PubMed ID: 17944567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFR.
    Bell DW; Gore I; Okimoto RA; Godin-Heymann N; Sordella R; Mulloy R; Sharma SV; Brannigan BW; Mohapatra G; Settleman J; Haber DA
    Nat Genet; 2005 Dec; 37(12):1315-6. PubMed ID: 16258541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Personalized, targeted treatment of non-small cell lung cancer].
    Wolf J
    Dtsch Med Wochenschr; 2011 Mar; 136(10):480-5. PubMed ID: 21365525
    [No Abstract]   [Full Text] [Related]  

  • 10. An update on the role of epidermal growth factor receptor inhibitors in non-small cell lung cancer.
    Edelman MJ
    Semin Oncol; 2005 Dec; 32(6 Suppl 10):S3-8. PubMed ID: 16459173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted therapy in lung cancer: the good, the bad, and the ugly.
    Gadgeel SM
    Clin Lung Cancer; 2009 Jan; 10(1):10-2. PubMed ID: 19289366
    [No Abstract]   [Full Text] [Related]  

  • 12. Americas Antibody Congress 2009. 21-23 September 2009, Washington DC, USA.
    Reyes CL
    IDrugs; 2009 Nov; 12(11):692-4. PubMed ID: 19844854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. For EGFR research, new targeted drugs mean new questions.
    Vastag B
    J Natl Cancer Inst; 2005 May; 97(9):628-30. PubMed ID: 15870431
    [No Abstract]   [Full Text] [Related]  

  • 14. Her2-neu: a target in lung cancer?
    Andre F; Le Chevalier T; Soria JC
    Ann Oncol; 2004 Jan; 15(1):3-4. PubMed ID: 14679110
    [No Abstract]   [Full Text] [Related]  

  • 15. Lung cancer in the era of targeted therapy: a cytologist's perspective.
    Zakowski MF
    Arch Pathol Lab Med; 2013 Dec; 137(12):1816-21. PubMed ID: 23597048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can epidermal growth factor receptor-fluorescent in situ hybridization predict clinical benefit from cetuximab treatment in patients with non-small-cell lung cancer?
    Takano T; Ota S; Hori A; Seki N; Eguchi K
    J Clin Oncol; 2009 Jan; 27(3):464-5; author reply 465-7. PubMed ID: 19064956
    [No Abstract]   [Full Text] [Related]  

  • 17. New approaches in the management of lung cancer.
    Kris M
    J Natl Compr Canc Netw; 2005 Nov; 3 Suppl 1():S22-4. PubMed ID: 16280107
    [No Abstract]   [Full Text] [Related]  

  • 18. Precision Diagnosis and Treatment for Advanced Non-Small-Cell Lung Cancer.
    Reck M; Rabe KF
    N Engl J Med; 2017 Aug; 377(9):849-861. PubMed ID: 28854088
    [No Abstract]   [Full Text] [Related]  

  • 19. Individualised treatment in non-small cell lung cancer: precise tissue diagnosis for all?
    Booton R; Blackhall F; Kerr K
    Thorax; 2011 Apr; 66(4):273-5. PubMed ID: 21345972
    [No Abstract]   [Full Text] [Related]  

  • 20. [Molecular target therapy: a new method in treatment of lung cancer].
    Chen LA
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(37):2599-602. PubMed ID: 17198582
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.